A patient is taking an FGA for schizophrenia. The nurse notes ...

[sam.t96]

A patient is taking an FGA for schizophrenia. The nurse notes that the patient has trouble speaking and chewing and observes slow, wormlike movements of the patient's tongue. The nurse recognizes which adverse effect in this patient?
 
  a. Acute dystonia
  b. Akathisia
  c. Parkinsonism
  d. Tardive dyskinesia

Question 2

A patient complains to the nurse that the clonidine Catapres recently prescribed for hyperten-sion is causing drowsiness. Which response by the nurse to this concern is appropriate?
 
  a. Drowsiness is a common side effect in-itially, but it will lessen with time.
  b. You may also experience orthostatic hy-potension along with the drowsiness.
  c. You may be at risk for addiction if you have central nervous system side effects.
  d. You should discontinue the medication and contact your prescriber.

[sierrahalpin]

Answer to Question 1

D
Tardive dyskinesia can occur in patients during long-term therapy with FGAs. This patient shows signs of this adverse effect. Acute dystonia is characterized by severe spasm of muscles in the face, tongue, neck, or back and by opisthotonus. Akathisia is characterized by constant motion. Parkinsonism is characterized by bradykinesia, drooling, tremor, rigidity, and a shuffling gait.

Answer to Question 2

A
CNS depression, evidenced in this patient by drowsiness, is common in about 35 of the popu-lation. These responses become less intense with continued drug use. Orthostatic hypotension is less likely with clonidine, because its antihypertensive effects are not posture dependent. The experience of drowsiness does not indicate abuse potential. The patient should not discontinue the medication abruptly because of the potential for rebound hypertension; the patient should contact the prescriber before stopping the medication.

[sam.t96]

Thanks

[sierrahalpin]

Welcome